Skip to main content

Henry Schein stock price and financials

  • HSIC · Nasdaq
  • Distribution
  • Health Care Distributors
  • S&P 500
$86.22+0.09%Close 13 Nov 2026
Market value
$9.29B
P/E
22.07
EV / EBITDA
14.21
Beta · 1 year
0.61
Return · 1 year
+18.4%
52-week range$68.70 — $92.18

Share price close 16 Nov 2026

−3.1%1 monthHigh $88.74Low $82.50
$82$84$86$88$90Q3 FY2026 report filed 3 Nov 202623 Oct29 Oct4 Nov10 Nov16 Nov
+15.9%6 monthsHigh $90.86Low $72.69
$70$75$80$85$90$95Q2 FY2026 report filed 4 Aug 2026Q3 FY2026 report filed 3 Nov 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+11.5%year to dateHigh $90.86Low $68.99
$60$70$80$90$100Q4 FY2025 report filed 24 Feb 2026Q1 FY2026 report filed 5 May 2026Q2 FY2026 report filed 4 Aug 2026Q3 FY2026 report filed 3 Nov 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+18.0%1 yearHigh $90.86Low $68.99
$60$70$80$90$100Q4 FY2025 report filed 24 Feb 2026Q1 FY2026 report filed 5 May 2026Q2 FY2026 report filed 4 Aug 2026Q3 FY2026 report filed 3 Nov 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+24.7%3 yearsHigh $90.86Low $62.03
$60$70$80$90$100Q3 FY2023 report filed 28 Nov 2023Q4 FY2023 report filed 28 Feb 2024Q1 FY2024 report filed 7 May 2024Q2 FY2024 report filed 6 Aug 2024Q3 FY2024 report filed 5 Nov 2024Q4 FY2024 report filed 25 Feb 2025Q1 FY2025 report filed 5 May 2025Q2 FY2025 report filed 5 Aug 2025Q3 FY2025 report filed 4 Nov 2025Q4 FY2025 report filed 24 Feb 2026Q1 FY2026 report filed 5 May 2026Q2 FY2026 report filed 4 Aug 2026Q3 FY2026 report filed 3 Nov 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+36.9%10 yearsHigh $91.36Low $45.01
$40$60$80$100Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

Henry Schein reported revenue of $13.2 billion for fiscal year 2025 (the twelve months to 27 Dec 2025), up 4.0% from fiscal 2024. Net income was $398 million and diluted earnings per share $3.27.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 26 Sep 2026), revenue was $3.47 billion, up 4.0% from a year earlier.

Figures from Henry Schein's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 3 Nov 2026.

Against Health Care

Growth
Lower half
Revenue +5.4% a year over five years · 26th of 37
Profitability
Lower half
Return on invested capital 7.6%, five-year average · 24th of 38
Balance sheet
Bottom quarter
Net debt 3.6× EBITDA · 31st of 38
Valuation
Below the median
P/E 22.1 · 10th of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2025
$13.18B+4.0%
Net income
$398.0M+2.1%
Diluted EPS
$3.27+7.2%
Gross margin
31.1%−0.6 pts
Free cash flow
$573.0M−18.1%
Net debt
$3.28B+19.4%

Fiscal 2025 against fiscal 2024; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2016–2025

  • Revenue
  • Net income
$0$5B$10B$15BRevenue, FY16: $11.57BNet income, FY16: $506.78MFY16Revenue, FY17: $12.46BNet income, FY17: $406.3MFY17Revenue, FY18: $13.2BNet income, FY18: $535.88MFY18Revenue, FY19: $9.99BNet income, FY19: $694.73MFY19Revenue, FY20: $10.12BNet income, FY20: $404MFY20Revenue, FY21: $12.4BNet income, FY21: $631MFY21Revenue, FY22: $12.65BNet income, FY22: $538MFY22Revenue, FY23: $12.34BNet income, FY23: $416MFY23Revenue, FY24: $12.67BNet income, FY24: $390MFY24Revenue, FY25: $13.18BNet income, FY25: $398MFY25

Latest quarter · Q3 FY2026 to 26 Sep 2026, filed 3 Nov 2026 · Full results →

Revenue
$3.47B+4.0% on a year
Gross margin
31.8%+1.1 pts on a year
Operating income
$193.0M+17.7% on a year
Net income
$119.0M+17.8% on a year
Diluted EPS
$1.06+26.2% on a year
Free cash flow
$131.0M−7.1% on a year

Comparable companies All of Health Care →

Henry Schein beside the other S&P 500 members in Health Care Distributors, then the largest in Health Care, by market value.

Henry Schein and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
Henry ScheinHSIC$9.29B+0.1%+18.4%+6.2%3.1%22.1
McKesson CorporationMCK$127.9B+2.4%+31.2%+8.2%1.1%27.2
CencoraCOR$68.14B+2.8%−1.2%+5.1%0.8%26.0
Cardinal HealthCAH$65.30B+1.1%+37.6%+10.0%0.7%35.9
Eli LillyLLY$1.37T+1.1%+41.8%+45.5%31.9%49.6
Johnson & JohnsonJNJ$686.1B+0.8%+47.0%+7.8%16.2%42.6
AbbVieABBV$525.9B+0.2%+26.5%+10.7%15.7%51.1

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Margins fiscal 2016–2025

  • Gross
  • Operating
  • Net
0%20%40%31.1%5.0%3.0%FY16FY19FY22FY25

Henry Schein revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By segment

Henry Schein revenue by segment, by fiscal year
RevenueFY 2022FY 2023FY 2024FY 2025
Global Distribution and Value-Added Services$10.97B$10.56B−3.8%$10.76B+1.9%$11.14B+3.5%
Global Specialty Products$1.27B$1.33B+4.6%$1.45B+8.6%$1.54B+6.8%
Global Technology$549.0M$602.0M+9.7%$630.0M+4.7%$675.0M+7.1%
Total revenue$12.65B$12.34B$12.67B$13.18B

By region

Henry Schein revenue by region, by fiscal year
RevenueFY 2023FY 2024FY 2025
United States$8.66B$8.82B+1.9%$9.10B+3.1%
Other$3.68B$3.85B+4.7%$4.09B+6.2%
Total revenue$12.34B$12.67B$13.18B

Financial statements

Fiscal years, the latest ending 27 Dec 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

Henry Schein income statement, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$11.57B$12.46B$13.20B$9.99B$10.12B$12.40B$12.65B$12.34B$12.67B$13.18B
Revenue growth+8.9%+7.7%+5.9%−24.4%+1.3%+22.6%+2.0%−2.4%+2.7%+4.0%
Gross profit$3.23B$2.75B$2.91B$3.09B$2.82B$3.67B$3.83B$3.86B$4.02B$4.11B
Operating income$771.6M$669.8M$600.6M$718.3M$535.0M$852.0M$747.0M$615.0M$621.0M$653.0M
Net income$506.8M$406.3M$535.9M$694.7M$404.0M$631.0M$538.0M$416.0M$390.0M$398.0M
Diluted EPS$3.10$2.57$3.49$4.65$2.82$4.45$3.91$3.16$3.05$3.27
Gross margin27.9%22.0%22.0%31.0%27.8%29.6%30.3%31.3%31.7%31.1%
Operating margin6.7%5.4%4.5%7.2%5.3%6.9%5.9%5.0%4.9%5.0%
Net margin4.4%3.3%4.1%7.0%4.0%5.1%4.3%3.4%3.1%3.0%

Cash flow

Henry Schein cash flow, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow$642.6M$545.5M$684.7M$654.1M$599.0M$710.0M$602.0M$500.0M$848.0M$712.0M
Capital expenditure$70.18M$62.40M$71.28M$76.22M$49.00M$79.00M$96.00M$147.0M$148.0M$139.0M
Free cash flow$572.4M$483.1M$613.4M$577.9M$550.0M$631.0M$506.0M$353.0M$700.0M$573.0M

Balance sheet and shares

Henry Schein balance sheet and shares, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$62.38M$174.7M$56.88M$106.1M$421.2M$118.0M$117.0M$171.0M$122.0M$156.0M
Total debt$781.4M$924.4M$1.94B$998.3M$1.00B$1.22B$1.50B$2.74B$2.87B$3.44B
Shareholders' equity$2.79B$2.81B$2.96B$3.00B$3.35B$3.42B$3.45B$3.65B$3.39B$3.25B
Diluted shares164M158M154M149M143M142M138M132M128M122M

Quarterly figures

The last eight fiscal quarters, the latest ending 26 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

Henry Schein quarterly financial figures
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$3.19B$3.17B$3.24B$3.34B$3.44B$3.37B$3.46B$3.47B
Revenue, year on year+5.8%−0.1%+3.3%+5.2%+7.7%+6.3%+6.7%+4.0%
Gross margin31.1%31.6%31.4%30.7%30.9%31.8%31.8%31.8%
Operating income$155.0M$175.0M$151.0M$164.0M$163.0M$182.0M$171.0M$193.0M
Net income$94.00M$110.0M$86.00M$101.0M$101.0M$107.0M$94.00M$119.0M
Diluted EPS$0.75$0.88$0.70$0.84$0.85$0.92$0.82$1.06
Free cash flow$168.0M$6.00M$88.00M$141.0M$338.0M−$122.0M$212.0M$131.0M

Operating KPIs

The operating figures Henry Schein reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

Henry Schein operating KPIs
KPILatestPeriodChange on a yearRecent periods
Global Dental revenue$1.8Bquarter to 26 Sep 2026up 5.4%
Global Dental Merchandise revenue$1.3Bquarter to 26 Sep 2026up 7.0%
Global Medical revenue$1.1Bquarter to 26 Sep 2026up 1.1%
Global Dental Equipment revenue$449.0Mquarter to 26 Sep 2026up 2.0%
Global Value-Added Services revenue$62.0Mquarter to 26 Sep 2026down 3.1%
Global Distribution and Value-Added Services revenue$2.9Bquarter to 26 Sep 2026up 3.7%
Global Specialty Products revenue$391.0Mquarter to 26 Sep 2026up 6.0%
Global Technology revenue$181.0Mquarter to 26 Sep 2026up 4.6%
United States revenue$9.1Bfiscal year to 27 Dec 2025up 3.1%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was Henry Schein's revenue in fiscal 2025?

$13.2 billion for fiscal year 2025 (the twelve months to 27 Dec 2025), as reported in its annual report.

What was Henry Schein's net income in fiscal 2025?

$398 million for fiscal year 2025 (the twelve months to 27 Dec 2025).

What were Henry Schein's diluted earnings per share in fiscal 2025?

$3.27 for fiscal year 2025 (the twelve months to 27 Dec 2025).

What is Henry Schein's gross margin?

31.1% for fiscal year 2025 (the twelve months to 27 Dec 2025): gross profit divided by revenue.

What is Henry Schein's operating margin?

5.0% for fiscal year 2025 (the twelve months to 27 Dec 2025): operating income divided by revenue.

How much free cash flow did Henry Schein generate in fiscal 2025?

$573 million for fiscal year 2025 (the twelve months to 27 Dec 2025): operating cash flow less capital expenditure.

Where does Henry Schein's revenue come from?

In fiscal 2025, by region: United States $9.10B (69%), Other $4.09B (31%), out of $13.18B in all, as stated in its annual report.

In the terminal

Twenty years of Henry Schein's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans